加拉宁受体:G蛋白依赖信号传递及其他方面
Judit Oláh1, Eszter Soltész-Katona1, Hana Kaci1
1Institute of Molecular Life Sciences, Centre of Excellence of the Hungarian Academy of Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary.
Biomolecules
|February 27, 2026
概括
能系统涉及素受体 (GalR1-3),调节关键的生物功能,并与阿尔茨海默氏症和癌症等疾病有关. 了解其复杂的信号通路对于开发新疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 氨酸受体 (GalR1-3) 是由像氨酸这样的神经激活的G蛋白结合受体.
- 这些受体在大脑和外围组织中分布广泛,调节各种生理过程.
- 能系统的失调与神经和代谢障碍有关,包括阿尔茨海默病,和糖尿病.
研究的目的:
- 审查了解加拉林受体信号通路的最新进展.
- 突出G蛋白依赖性和G蛋白独立性信号机制的作用.
- 强调这些知识对于开发向治疗的重要性.
主要方法:
- 关于加拉受体信号传递的最近研究的文献综述.
- 对G蛋白介导通路 (Gαi/o和Gαq/11) 和β-阿雷斯依赖通路的分析.
- 合成关于受体表达和生理功能的信息.
主要成果:
- 氨酸受体通过不同的信号级联进行介导:GalR1/3通过Gαi/o抑制cAMP,而GalR2通过Gαq/11.11激活PLC.
- 此外,GalR2还参与了依赖于β-阿雷斯的途径.
- 能系统影响饮食,神经保护,学习,记忆,心血管/功能和感觉.
结论:
- 能系统的复杂信号网络涉及多个路径.
- 进一步阐明这些途径对于设计特定的激动剂至关重要.
- 准加拉林受体信号传递对各种疾病具有治疗潜力.
相关概念视频
G Protein-coupled Receptors
18.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.3K
GPCRs Regulate Adenylyl Cylase Activity
7.8K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.8K
Activation and Inactivation of G Proteins
11.9K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.9K
G-protein Coupled Receptors
133.0K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
133.0K
Amplifying Signals via Enzymatic Cascade
18.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
Transducer Mechanism: G Protein–Coupled Receptors
5.6K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
5.6K


